DONALD WILLIAMS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

PALISADE BIO, INC.

Filing Date Source Excerpt
2021-10-07 Mr. Williams received a B.A. in accountancy from Southern Illinois University and completed the director education and certification program at the University of California, Los Angeles Anderson School of Business.
2022-08-31 Donald Williams
2022-08-31 Donald Williams ... In accordance with the merger transaction with Seneca Biopharma, Inc. ("Seneca") effected April 27, 2021, the board of directors of Seneca (the "Seneca Board") appointed Thomas Hallam, Ph.D., James R. Neal, Stephanie Diaz, Robert J. Trenschel, D.O. and Don Williams to the Board.
2023-04-21 Mr. Williams received a B.A. in accountancy from Southern Illinois University and completed the director education and certification program at the University of California, Los Angeles Anderson School of Business.
2024-02-06 Donald Williams(7) Includes (i) 30,000 shares of common stock and (ii) 1,258 shares of common stock underlying stock options.
2024-05-22 Mr. Williams received a B.A. in accountancy from Southern Illinois University and completed the director education and certification program at the University of California, Los Angeles Anderson School of Business.

Data sourced from SEC filings. Last updated: 2026-03-09